Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease. [Phase 1]

View source ↗

Summary

Phase 1 study assessing the pharmacokinetics and pharmacodynamics of dabigatran etexilate in patients with stable severe renal disease has completed, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Renal Insufficiency, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2015-01-13